CA
NZ
UK
AU
IND
US
US equities stabilised on Monday after opening sharply lower, as markets absorbed the economic implications of escalating conflict in the Middle East. A weekend escalation involving US strikes on Iranian targets introduced immediate geopolitical risk, but a broad intraday rebound suggested that liquidity conditions …
Gross margin expanded to 56.8%, up 11 percentage points from the prior quarter, supported by higher pricing, disciplined cost execution, and favorable product mix. Operating income totaled $6.4 billion, representing a 47% operating margin. Non-GAAP diluted earnings per share were $4.78, up 58% sequentially …
Netflix, Inc. enters 2026 following a year in which it met or exceeded its stated financial objectives. Revenue grew 16% in 2025, supported by stronger member acquisition, improved retention, and rapid expansion of its advertising business. Operating profit rose approximately 30%, reflecting both revenue …
Microsoft Corporation enters the 2025–2026 fiscal period with sustained double-digit growth across revenue and earnings, supported primarily by cloud computing and artificial intelligence adoption. Quarterly revenue reached $81.3 billion, increasing 17% in constant currency. Operating income rose 21%, while earnings per share climbed 24% …
Meta Platforms entered 2026 following a year of robust financial expansion. In the fourth quarter of 2025, total revenue reached $58.9 billion, representing a 25% year-over-year increase. Advertising remained the dominant contributor, with Family of Apps ad revenue of $58.1 billion, up 24% (23% …
Xponential Fitness (NYSE:XPOF) plunged 47.08% to $4.26 on February 27, 206, wiping out nearly half itsmarket capitalizationin one session, with volume crossing 1.02 million shares and indicating aggressive institutional selling rather than retail-drivenvolatility.
PAR Technology (NYSE:PAR) dropped 27.03% to $16.39 on February 27, 2026, as investors reacted to concerns over slowing growth in the restaurant SaaS sector.
LiveWire Group (NYSE:LVWR) fell 28.21% to $1.68 on February 27, 2026, signaling deep skepticism toward EV motorcycle demand and scale economics.
Emergent BioSolutions (NYSE:EBS) fell 26.58% to $8.15 as investors responded to ongoing post-pandemicrevenuenormalization. The decline reflects reduced demand for pandemic-related products, highlighting the company’s exposure to fluctuations in vaccine sales and government contracts.
Ginkgo Bioworks (NYSE:DNA) declined 30.48% to $6.75 on February 27, 2026 with heavy selling pressure reflecting a repricing of long-duration biotech growth stocks and volume exceeding 3M shares, indicating broad participation.
Please wait processing your request...